Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this free, full length talk
Topics Covered
- Why INFβ was chosen as a therapy for COVID-19
- Previous use of INFβ by inhalation
- Safety of INFβ as a therapy
- SNG001 mode of delivery
- SNG001 clinical trials and future prospects
Biography
Stephen is Medical Research Council Clinical Professor of Immunopharmacology at the University of Southampton with a research interest in the mechanisms of asthma and allergy, with over 1000 peer reviewed publications. His research has focused on the roles of air pollutants, allergens, and viruses in driving airway inflammation, and remodelling involving injury to the epithelium and aberrant repair. In 2003 he cofounded a University of Southampton spin out company, Synairgen, to develop inhaled interferon-beta for the treatment of viral exacerbations of asthma and COPD. He was the founder chair of the Committee on the Medical Effects of Air Pollutants, chair of the Expert Panel on Air quality Standards, the Hazardous Substances Advisory Committee, and was a member of the Royal Commission on Environmental Pollution. He is Special Advisor to the RCP on Air Quality and in 2016 and 2020 published two influential RCP and RCPCH reports on the health impacts on air pollution.
He has been President of the British Society for Allergy and Clinical Immunology, British Thoracic Society, British Association for Lung Research and the Collegium Internationale Allergologicum. He has been Chair of MRC Population and Systems Medicine Board, the MRC Translational Research Group, Member of MRC and NERC Strategy Boards, Chaired the Main Panel A (Health and Life Sciences) of the UK Research Excellence Framework 2014, and is Deputy Convenor of the Hong Kong RAE 2020.
His contributions have been recognised by a number of awards including The King Faisal International Prize in Medicine, the J Allyn Taylor International Prize in Medicine, The British Thoracic Society Medal, Distinguished International Fellow of the American College of Allergy Asthma and Immunology, Lifetime Achievement Award of the World Allery Organisation, and is the 2020 recipient of the RCP Faculty of Public Health Bazalgette Champion of Evidence Award. He has Honorary Degrees from the University of Ferrara Italy, Krakow Poland, Naples Frederico II, Italy and Exeter, UK. He was a Founder Member of the Academy of Medical Sciences, served on its Council and is Founder Chair of the Clinical and Veterinary Section of the Academia Europaea. In 2011, he was appointed Commander of the Order of the British Empire in the Queen’s New Year Honours for Services to Clinical Science.
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Holgate, S. (2020, May 27). INFβ therapy for COVID-19: the new SNG001 drug [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/HTLL1474.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Stephen Holgate has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Playlist: Interviews on Covid-19
Transcript
Quiz
Disclaimer: This quiz is intended for learning assessment purposes only and does not grant any certification or credit.
If you are interested in getting a certificate for watching the talk, follow the instructions in this talk's Accreditation Information (where available.)